skip to main content
Idioma:
Refinado por: materia: Female eliminar materia: Pharmacology. Drug Treatments eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Material Type:
Artículo 		Añadir a Mi Portal

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts

MILACIC, Vesna ; DI CHEN ; RONCONI, Luca ; LANDIS-PIWOWAR, Kristin R ; FREGONA, Dolores ; PING DOU, Q

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (21), p.10478-10486 [Revista revisada por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponible

Citas Citado por
2
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Material Type:
Artículo 		Añadir a Mi Portal

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Cavo, Michele, Prof ; Tacchetti, Paola, MD ; Patriarca, Francesca, MD ; Petrucci, Maria Teresa, MD ; Pantani, Lucia, MD ; Galli, Monica, MD ; Di Raimondo, Francesco, Prof ; Crippa, Claudia, MD ; Zamagni, Elena, MD ; Palumbo, Antonio, MD ; Offidani, Massimo, MD ; Corradini, Paolo, Prof ; Narni, Franco, MD ; Spadano, Antonio, MD ; Pescosta, Norbert, MD ; Deliliers, Giorgio Lambertenghi, Prof ; Ledda, Antonio, MD ; Cellini, Claudia, MD ; Caravita, Tommaso, MD ; Tosi, Patrizia, MD ; Baccarani, Michele, Prof

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085 [Revista revisada por pares]

Kidlington: Elsevier Ltd

Texto completo disponible

Citas Citado por
3
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Material Type:
Artículo 		Añadir a Mi Portal

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma

Tosi, P ; Zamagni, E ; Cellini, C ; Ronconi, S ; Patriarca, F ; Ballerini, F ; Musto, P ; Di Raimondo, F ; Ledda, A ; Lauria, F ; Masini, L ; Gobbi, M ; Vacca, A ; Ria, R ; Cangini, D ; Tura, S ; Baccarani, M ; Cavo, M

Haematologica (Roma), 2002-04, Vol.87 (4), p.408-414 [Revista revisada por pares]

Pavia: Haematologica

Texto completo disponible

Citas Citado por
4
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
Material Type:
Artículo 		Añadir a Mi Portal

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

CAVO, M ; BANDINI, G ; MOTTA, M ; RIZZI, S ; TURA, S ; BENNI, M ; GOZZETTI, A ; RONCONI, S ; ROSTI, G ; ZAMAGNI, E ; LEMOLI, R ; BONINI, A ; BELARDINELLI, A

Bone marrow transplantation (Basingstoke), 1998-07, Vol.22 (1), p.27-32 [Revista revisada por pares]

Basingstoke: Nature Publishing Group

Texto completo disponible

Citas Citado por
5
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Material Type:
Artículo 		Añadir a Mi Portal

Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy

ZINZANI, P. L ; MARTELLI, M ; GHERLINZONI, F ; MORETTI, L ; DE RENZO, A ; MAZZA, P ; PAVONE, E ; SABATTINI, E ; AMENDOLA, A ; BENDANDI, M ; PILERI, S. A ; MANDELLI, F ; MAGAGNOLI, M ; TURA, S ; ZACCARIA, A ; RONCONI, F ; CANTONETTI, M ; BOCCHIA, M ; MARRA, R ; GOBBI, M ; FALINI, B

Blood, 1998-08, Vol.92 (3), p.790-794 [Revista revisada por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponible

Citas Citado por
6
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
Material Type:
Artículo 		Añadir a Mi Portal

Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

Zinzani, PL ; Magagnoli, M ; Moretti, L ; Battista, R ; Ronconi, F ; De Renzo, A ; Zaccaria, A ; Gentilini, P ; Guardigni, L ; Gherlinzoni, F ; Cellini, C ; Fattori, PP ; Bendandi, M ; Bocchia, M ; Aitini, E ; Tura, S

Haematologica (Roma), 1999-11, Vol.84 (11), p.1002-1006 [Revista revisada por pares]

Pavia: Haematologica

Texto completo disponible

Citas Citado por
7
Preventing fungal infection in neutropenic patients with acute leukemia : fluconazole compared with oral amphotericin B
Preventing fungal infection in neutropenic patients with acute leukemia : fluconazole compared with oral amphotericin B
Material Type:
Artículo 		Añadir a Mi Portal

Preventing fungal infection in neutropenic patients with acute leukemia : fluconazole compared with oral amphotericin B

MENICHETTI, F ; DEL FAVERO, A ; BARBUI, T ; FASOLA, G ; MANDELLI, F ; MARTINO, P ; BUCANEVE, G ; MICOZZI, A ; D'ANTONIO, D ; RICCI, P ; CAROTENUTO, M ; LISO, V ; NOSARI, A. M

Annals of internal medicine, 1994-06, Vol.120 (11), p.913-918 [Revista revisada por pares]

Philadelphia, PA: American College of Physicians

Texto completo disponible

Citas Citado por
8
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
Material Type:
Artículo 		Añadir a Mi Portal

A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)

Ferrara, Felicetto ; Vecchio, Luigi Del ; Mele, Giuseppina ; Rametta, Vincenzo ; Ronconi, Fioravante ; Montuori, Renato

Cancer, 1989-08, Vol.64 (4), p.789-792 [Revista revisada por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1989  (1)
  2. 1989Hasta1993  (1)
  3. 1994Hasta1997  (1)
  4. 1998Hasta1999  (3)
  5. Después de 1999  (3)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora